By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Schneider Shorts 24.06.2022 – bad choices in Dresden end with research misconduct findings, where the money for heart stem cell research went, nicotine and Photoshop fraud fail in clinical trials, with the most authoritative papermill guidelines, a coronavirus zapper from Italy, and a plant science professor who wasn’t so great after all.
Schneider Shorts 1.04.2022 – Bottomless stupidity of Russian fascists, with a Welsh hand-reading eugenicist, a man who cures everything with glutathione, a match made in heaven, sad mathematicians who can’t party in St Petersburg, a reminder that Elsevier is a predatory publisher, and how coffee can cure anxiety.
Schneider Shorts of 25.03.2022 – University of Louisville canonizes a fraudster, a Peruvian sexual harasser puts critic on trial, a sacked CEO with a new biotech startup, French COVID quacks being creative, some interesting corrections, and why China’s science is the best in the world.
Schneider Shorts 29.10.2021 – fluvoxamine officially a COVID-19 game-changer, lab leak still just a conspiracy theory, Retraction Watchdogs catch a cheating student, papermill customers get sanctioned, and lawsuits everywhere: Sabatini sues Whitehead, Macchiarini trial begins in Sweden, Athira Pharma separates from cheating CEO while facing investor lawsuits, and Raoult finally facing criminal charges (theoretically).
Schneider Shorts 1.10.2021 – with antivaxxers big and small, Brazilian killers, Dutch research integrity, Russian science kakistocracy, the wonders of peer review, how COVID-19 miracle cures work, and a Twitter scandal of academic fraud which was too good to be true.
“I have a passion to solve a problem that is facing millions. I could have a job that makes more money, has normal hours, but this is where I should be right now.” Dr Leen Kawas, CEO of Althira Pharma
For Better Science